Estadísticas de Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials

Visitas totales

views
Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials 1

Visitas totales por mes

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 1
October 2024 0
November 2024 0

Visitas de archivo

views
Meza_Angi2021.pdf 26